
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NTLA] Intellia Therapeutics Inc
Data updated 2025-Apr-30 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Apr-30 Wednesday
Open | $8.04 | High | $8.94 +11.19% |
---|---|---|---|
Close | $8.87 | Low | $7.90 -1.74% |
Volume | 4.22 Million 0.90x | Volatility | 13.16% |
Change |
+$0.67
+8.17%
|
Streak | ↑ 1 days +8.17% |
20d SMA | $7.51 +18.1% | 50d SMA | $8.76 +1.2% | 100d SMA | $10.10 -12.2% | 200d SMA | $15.14 -41.4% |
RSI | 58 | MACD | 0.25 | ADX | 19.0 | Stochastic Oscillator | 86.4 82.6 |
CCI | 115.6 | ATR | 0.69 | OBV | 22.8 Million | Chaikin A/D | -78.2 Million |
Market Cap | 2.58 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 65.7 | Price/Book (mrq) | 2.46 | EV/Revenue (ttm) | 49.1 | EV/EBITDA (ttm) | -3.52 |
% Held by Insiders | 1.33% | % Held by Institutions | 87.35% | Shares Short | 12.6 M | Shares Short (prior month) | 11 M |
Short Ratio | 6.28 | Short % of Outstanding | 13.13% | Short % of Float | 13.35% | Shares Short Change (mom) | +15.0% |
Revenue/Share (ttm) | $0.41 | Profit Margin (ttm) | 0.00% | Operating Margin (ttm) | EBITDA (ttm) | -506 M | |
Diluted EPS (ttm) | $-5.42 | Current Ratio (mrq) | 8.66 | Return on Assets (ttm) | -22.83% | Return on Equity (ttm) | -42.10% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | Operating Cash Flow (ttm) | -394 M | Free Cash Flow (ttm) | -268 M | ||
Choose view type
Daily Performance for Intellia Therapeutics Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Intellia Therapeutics Inc up to close of 2025-Apr-30 at $8.87
20-year Performance Benchmarks for Intellia Therapeutics Inc:
Related to Intellia Therapeutics Inc
Information for Intellia Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-30 on Google
SEC Reports : Quarterly reports around 2025-Apr-30 on SEC Edgar
Compare Intellia Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Intellia Therapeutics Inc
Industry : Biotechnology industry performance which includes Intellia Therapeutics Inc